Trial intelligence / Profile preview

A-CP HA Kit (PRP + HA) vs HA vs Placebo in Knee Osteoarthritis

NCT03201614Unknown

Sponsor
Regen Lab
Start
May 2018
Primary completion
Apr 2022
Modality
Adipose-derived MSCs, Bone Marrow MSCs
Countries
1
01

Overview

Randomised, double-blind trial of platelet-rich plasma in knee osteoarthritis (OA), sponsored by Regen Lab. Primary endpoints: Variation in overall OA-related symptoms at 6 months and Variation in pain at walking (WOMAC A1 score) at 6 months. Status: unknown.

02

Drugs

platelet-rich plasma
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT03201614.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03201614.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call